Latest Breaking News On - Department of thoracic - Page 1 : comparemela.com

BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event

BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoRichard waldronMecbotamab vedotinBruce mackleOffice of orphan drug productsMd anderson cancer centerExchange commissionDepartment of thoracicLifesci advisorsBioatla incAtla presented phaseTrial dataAmerica conferenceLung cancerConditionally active biologic

Mapping The Genetic Landscape Of Lung Cancer

An international team of scientists today announced the results of a systematic effort to map the genetic changes underlying lung cancer, the world’s leading cause of cancer deaths.

United statesNational institutes of healthUniversity of texasMassachusetts institute of technologyNew yorkMemorial sloan kettering cancer centerDana farber cancer instituteUniversity of texas southwestern medical centerUnited kingdomBaylor college of medicineWashington universityAnn arborHidefumi sasakiKinjal shahRichard wilsonMarc ladanyi

Dr Tina Cascone Details Impact of Nivolumab Chemo-Immunotherapy on NSCLC

Tina Cascone, MD, PhD, of the University of Texas MD Anderson Cancer Center, discusses the impact of the CheckMate 77T study on the treatment approach for non–small cell lung cancer (NSCLC).

United statesTina casconeDivision of cancer medicineDepartment of thoracicUniversity of texas md anderson cancer centerCancer medicineNeck med oncCancer centerLung cancer

Perioperative Nivolumab Significantly Improves EFS in Previously Untreated Resectable NSCLC

Neoadjuvant treatment with nivolumab plus chemotherapy followed by surgery and adjuvant nivolumab resulted in a statistically significant improvement in event-free survival vs placebo plus chemotherapy, in patients with previously untreated resectable stage II to IIIB non-small cell lung cancer, according to data from the phase 3 CheckMate 77T trial.

United statesDepartment of thoracicUniversity of texas md anderson cancer centerNeck medical oncologyCancer centerLung cancer treatment research entersNeoadjuvant adjuvant nivolumabPerioperative nivolumabNon small cell lung cancerLung cancerCheckmate 77t

Dr Negrao on JDQ443 Plus TNO155 in Advanced, KRAS G12C–Mutated Solid Tumors

Marcelo Vailati Negrao, MD, discusses efficacy findings from the phase 1b/2 KontRASt-01 trial (NCT04699188) in patients with KRAS G12C–mutated solid tumors.

United statesMarcelo vailati negraoDivision of cancer medicineDepartment of thoracicUniversity of texas md anderson cancer centerNeck medical oncologyCancer medicineCancer centerLung cancerKontrast 01 trialPatients with kras g12c mutated solid tumorsThe university of texas md anderson cancer center